Literature DB >> 8027902

Drug treatment on demand--not.

L D Wenger1, M Rosenbaum.   

Abstract

Drug treatment on demand, appropriate and affordable drug treatment for injection drug users who are "ready" to enter a program, is a humane approach to drug treatment services and an important mechanism to halt the spread of HIV. However, drug treatment on demand is not a reality in the United States. In fact, due to funding cuts at federal, state, and local levels, entry into drug treatment programs has become increasingly more difficult over the past decade. In a NIDA-funded ethnographic study of methadone maintenance, i.v. drug use and AIDS, 70 heroin addicts who were out of treatment and actively seeking methadone maintenance were interviewed. In life-history interviews, the drug users described barriers to treatment, waiting-list experiences, and the impact of these experiences on their drug use, drug-using behavior, and emotional well-being. Respondents used many mechanisms to cope with the lack of availability of drug treatment slots, some of which have increased their risk of exposure to and spread of HIV. These findings indicate the need for an increase in the availability of subsidized methadone maintenance treatment slots "on demand" if individuals are to decrease their drug use and their high-risk behaviors. Drug treatment on demand is more than politically correct rhetoric. It is a necessary ingredient in reducing the harm caused by the use of illegal drugs.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8027902     DOI: 10.1080/02791072.1994.10472597

Source DB:  PubMed          Journal:  J Psychoactive Drugs        ISSN: 0279-1072


  13 in total

1.  Administrative, clinical, and ethical issues surrounding the use of waiting lists in the delivery of mental health services.

Authors:  Seth A Brown; Jefferson D Parker; Phillip R Godding
Journal:  J Behav Health Serv Res       Date:  2002-05       Impact factor: 1.505

2.  A brief telephone intervention targeting treatment engagement from a substance abuse program wait list.

Authors:  Jefferson D Parker; Cynthia L Turk; Lisa D Busby
Journal:  J Behav Health Serv Res       Date:  2002-08       Impact factor: 1.505

3.  Individual and system influences on waiting time for substance abuse treatment.

Authors:  Carey J A Carr; Jiangmin Xu; Cristina Redko; D Timothy Lane; Richard C Rapp; John Goris; Robert G Carlson
Journal:  J Subst Abuse Treat       Date:  2007-05-23

4.  Access to drug abuse treatment under Treatment on Demand policy in San Francisco.

Authors:  James L Sorensen; Joseph Guydish; Pamela Zilavy; Thomas B Davis; Alice Gleghorn; Marvin Jacoby; Clare Sears
Journal:  Am J Drug Alcohol Abuse       Date:  2007       Impact factor: 3.829

5.  Pathways of Substance Users Linking (Or Not) With Treatment.

Authors:  Cristina Redko; Richard C Rapp; Robert G Carlson
Journal:  J Drug Issues       Date:  2007

6.  Interim treatment: Bridging delays to opioid treatment access.

Authors:  Stacey C Sigmon
Journal:  Prev Med       Date:  2015-04-30       Impact factor: 4.018

7.  Waiting Time as a Barrier to Treatment Entry: Perceptions of Substance Users.

Authors:  Cristina Redko; Richard C Rapp; Robert G Carlson
Journal:  J Drug Issues       Date:  2006-09

8.  Inability to access addiction treatment and risk of HIV infection among injection drug users recruited from a supervised injection facility.

Authors:  M-J S Milloy; Thomas Kerr; Ruth Zhang; Mark Tyndall; Julio Montaner; Evan Wood
Journal:  J Public Health (Oxf)       Date:  2009-09-23       Impact factor: 2.341

9.  Dropout from interim methadone and subsequent comprehensive methadone maintenance.

Authors:  Jan Gryczysnki; Robert Schwartz; Kevin O'Grady; Jerome Jaffe
Journal:  Am J Drug Alcohol Abuse       Date:  2009-12-15       Impact factor: 3.829

10.  Bridging waitlist delays with interim buprenorphine treatment: initial feasibility.

Authors:  Stacey C Sigmon; Andrew C Meyer; Bryce Hruska; Taylor Ochalek; Gail Rose; Gary J Badger; John R Brooklyn; Sarah H Heil; Stephen T Higgins; Brent A Moore; Robert P Schwartz
Journal:  Addict Behav       Date:  2015-07-29       Impact factor: 3.913

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.